
Preventive Medicine
Latest News

Latest Videos

Shorts

Podcasts
CE Content
More News

The emergency use authorizations mark the first FDA-authorized prevention option for New World screwworm in dogs and cats.

Robert Armentano, DVM, DACVIM (SAIM), breaks down the biggest myths general practitioners still hold about diagnosing, treating, and vaccinating against leptospirosis in this episode of The Vet Blast Podcast, presented by dvm360.

Kaitlyn Krebs, DVM, MBA, and Kirsten White, DVM, break down the latest vaccine changes for canine and feline patients in this interview with dvm360.

Noga Schiller, DVM, explains what antibody titers can and can't tell you about a patient's protection, and why in-house testing may become a routine part of preventive care, on this episode of Vet Watch.

Elanco's TruCan Ultra Lyme-L4 is a combination therapy that aims to protect dogs against increasing health risks.

Zoetis' doramectin injection is now indicated for use in dairy cows, horses, sheep, swine, and deer to help mitigate NWS myiasis.

Feline vaccine may soon be available on the European market
The European Medicines Agency has recommended Nobivac NXT HCPChFelV for market authorization in the European Union.

A first-of-its-kind FDA approval for canine behavioral conditions, a potential milestone in veterinary vaccine technology, and new research complicating the picture of how H5N1 moves through dairy farm environments.

The oral moxidectin therapy is available over the counter.

Tick risk is no longer seasonal—Susan E. Little, DVM, PhD, DACVM (Parasitology), explains what’s changed and how to protect patients year-round.

Long-duration flea and tick collars can be a valuable, practical component of comprehensive parasite prevention.

New heartworm incidence map shows shifting hot spots
The American Heartworm Society has released the results of its latest survey mapping where the parasite's presence is growing, declining, or staying the same.

New webpage offers communication tips as studies show a substantial share of dog and cat owners still harbor concerns about vaccines.

Global survey finds many pets get parasites, yet owners want clearer prevention advice; vets urge year‑round flea, tick and heartworm protection.

UC Davis teams track HPAI H5N1 in northern elephant seals at Año Nuevo State Park, revealing symptoms, spread, and guidance on preventive measures for visitors.

Pennsylvania boosts HPAI surveillance and biosecurity as avian influenza hits chicken and turkey flocks; USDA testing ramps up to curb spread.

FDA approves first generic florfenicol–flunixin injectable (nixiFLOR) for bovine respiratory disease
The FDA has approved nixiFLOR, the first generic florfenicol-flunixin injectable, for treatment of bovine respiratory disease and control of associated fever in beef and nonlactating dairy cattle.

Christopher Lee, DVM, MPH, DACVPM, DACVM (Parasitology), explains why ticks and other parasites are expanding their range, why year-round isoxazoline use matters, and why indoor pets still face parasite risk.

Jane Sykes, BVSc, PhD, MPH, MBA, FNAP, summarizes the practical parts of the 2023 ACVIM consensus update on leptospirosis and explains what it means for general practice. She covers the biggest shift in recommendations, how to talk to owners about vaccine safety, when to test, and how to handle suspected cases safely in the clinic.

Elanco's monoclonal antibody therapy, Trutect, received a conditional license from the federal agency in 2023.

In a dvm360 interview, Christopher Lee, DVM, MPH, DACVPM, DACVM (Parasitology); Cert: FFC, CFV, RECOVER-ALS, recommends prioritizing epinephrine and species-specific administration to improve patient outcomes.

A concise Q&A for veterinarians summarizing the identification, reporting, treatment, prevention, and practical next steps as the New World screwworm approaches the US border.

"Our research shows that a one-size-fits-all approach to controlling avian pathogenic E coli infections is not effective," said Jai Mehat, BSc, PGCert, PhD, FHEA, coauthor of the study.

The study results place the American foulbrood prevention therapy closer to full USDA licensure.

Zoetis’ Vanguard Recombishield is a nonadjuvanted, recombinant injectable therapy.


















